Financial Snapshot

Revenue
$40.63K
TTM
Gross Margin
-294.46%
TTM
Net Earnings
-$16.13M
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
136.76%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
Q3 2024
Book Value
$18.02M
Q3 2024
Cash
Q3 2024
P/E
-0.3757
Nov 29, 2024 EST
Free Cash Flow
-$6.322M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995
Revenue $122.1K $3.520M $594.6K $16.56K $11.73K $77.72K $250.9K $0.00 $0.00 $0.00 $60.00K $10.00K $50.00K $110.0K $70.00K $130.0K $150.0K $50.00K $100.0K $80.00K $710.0K $50.00K $110.0K $220.0K $650.0K $670.0K $2.010M
YoY Change -96.53% 491.97% 3489.71% 41.19% -84.91% -69.03% -100.0% 500.0% -80.0% -54.55% 57.14% -46.15% -13.33% 200.0% -50.0% 25.0% -88.73% 1320.0% -54.55% -50.0% -66.15% -2.99% -66.67% -24.15%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995
Revenue $122.1K $3.520M $594.6K $16.56K $11.73K $77.72K $250.9K $0.00 $0.00 $0.00 $60.00K $10.00K $50.00K $110.0K $70.00K $130.0K $150.0K $50.00K $100.0K $80.00K $710.0K $50.00K $110.0K $220.0K $650.0K $670.0K $2.010M
Cost Of Revenue $375.8K $2.114M $184.2K $11.28K $8.772K $64.88K $60.32K $0.00 $0.00 $0.00 $0.00 $0.00 $30.00K $60.00K $20.00K $0.00 $20.00K $20.00K $0.00
Gross Profit -$253.7K $1.405M $410.4K $5.286K $2.959K $12.85K $190.6K $0.00 $0.00 $0.00 $50.00K $0.00 $30.00K $60.00K $50.00K $130.0K $130.0K $30.00K $100.0K
Gross Profit Margin -207.79% 39.93% 69.02% 31.91% 25.22% 16.53% 75.96% 83.33% 0.0% 60.0% 54.55% 71.43% 100.0% 86.67% 60.0% 100.0%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995
Selling, General & Admin $5.635M $8.536M $2.357M $1.445M $1.531M $1.315M $770.4K $667.1K $519.8K $570.0K $430.0K $360.0K $920.0K $640.0K $1.200M $1.370M $1.940M $2.290M $490.0K $360.0K $400.0K $300.0K $580.0K $1.090M $1.460M $1.070M $1.360M $1.520M $1.320M
YoY Change -33.98% 262.11% 63.09% -5.59% 16.42% 70.69% 15.48% 28.33% -8.8% 32.56% 19.44% -60.87% 43.75% -46.67% -12.41% -29.38% -15.28% 367.35% 36.11% -10.0% 33.33% -48.28% -46.79% -25.34% 36.45% -21.32% -10.53% 15.15% 1.54%
% of Gross Profit 607.37% 574.38% 27342.64% 51735.79% 10235.32% 404.16% 1840.0% 4000.0% 2283.33% 3880.0% 1761.54% 376.92% 1200.0% 400.0%
Research & Development $7.317M $6.846M $1.921M $389.00 $52.51K $32.59K $20.00K $130.0K $200.0K $280.0K $430.0K $460.0K $530.0K $530.0K $540.0K $190.0K $170.0K $170.0K $380.0K $520.0K $2.280M $4.730M $1.370M $1.650M $640.0K $880.0K
YoY Change 6.89% 256.44% 493639.07% -99.26% 61.12% -84.62% -35.0% -28.57% -34.88% -6.52% -13.21% 0.0% -1.85% 184.21% 11.76% 0.0% -55.26% -26.92% -77.19% -51.8% 245.26% -16.97% 157.81% -27.27% -35.29%
% of Gross Profit 487.14% 468.01% 7.36% 1774.59% 253.69% 560.0% 1533.33% 883.33% 1060.0% 415.38% 146.15% 566.67% 170.0%
Depreciation & Amortization $328.9K $291.7K $31.40K $1.820K $10.58K $17.90K $17.22K $9.270K $1.283K $20.00K $20.00K $20.00K $20.00K $20.00K $20.00K $20.00K $20.00K $20.00K $10.00K $30.00K $20.00K $30.00K $20.00K $20.00K $30.00K $30.00K $30.00K $30.00K $20.00K
YoY Change 12.76% 829.15% 1625.0% -82.8% -40.88% 3.94% 85.73% 622.53% -93.59% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 100.0% -66.67% 50.0% -33.33% 50.0% 0.0% -33.33% 0.0% 0.0% 0.0% 50.0% -33.33%
% of Gross Profit 20.76% 7.65% 34.43% 357.52% 139.29% 9.03% 40.0% 66.67% 33.33% 40.0% 15.38% 7.69% 100.0% 20.0%
Operating Expenses $12.95M $15.38M $4.278M $1.446M $1.583M $1.348M $770.4K $667.1K $519.8K $580.0K $560.0K $560.0K $1.200M $1.070M $1.660M $1.890M $2.470M $2.830M $680.0K $530.0K $570.0K $690.0K $1.090M $3.370M $6.190M $2.440M $3.000M $2.160M $2.200M
YoY Change -15.79% 259.57% 195.89% -8.69% 17.5% 74.92% 15.48% 28.33% -10.38% 3.57% 0.0% -53.33% 12.15% -35.54% -12.17% -23.48% -12.72% 316.18% 28.3% -7.02% -17.39% -36.7% -67.66% -45.56% 153.69% -18.67% 38.89% -1.82% -17.29%
Operating Profit -$13.21M -$13.98M -$3.867M -$1.440M -$1.580M -$1.335M -$579.8K -$667.1K -$519.8K -$580.0K -$560.0K -$560.0K -$1.150M -$1.070M -$1.630M -$1.830M -$2.420M -$2.700M -$550.0K -$500.0K -$470.0K
YoY Change -5.51% 261.38% 168.49% -8.86% 18.41% 130.21% -13.09% 28.33% -10.38% 3.57% 0.0% -51.3% 7.48% -34.36% -10.93% -24.38% -10.37% 390.91% 10.0% 6.38%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995
Interest Expense $144.2K $53.53K $11.90K $10.70K -$885.00 $3.963K $37.61K $2.871K $2.053K $0.00 -$100.0K -$110.0K -$180.0K $1.570M -$1.330M -$90.00K -$90.00K -$90.00K -$120.0K -$100.0K -$100.0K -$100.0K -$100.0K -$80.00K -$40.00K -$120.0K -$120.0K -$130.0K -$120.0K
YoY Change 169.38% 349.93% 11.17% -1309.27% -122.33% -89.46% 1210.07% 39.84% -100.0% -9.09% -38.89% -111.46% -218.05% 1377.78% 0.0% 0.0% -25.0% 20.0% 0.0% 0.0% 0.0% 25.0% 100.0% -66.67% 0.0% -7.69% 8.33% 0.0%
% of Operating Profit
Other Income/Expense, Net -$563.4K -$30.48K $0.00 $0.00 $10.00K $0.00 $0.00 $10.00K $0.00 $0.00 $0.00
YoY Change 1748.39% -100.0% -100.0%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995
Pretax Income -$13.77M -$14.01M -$21.24K -$10.19K -$1.580M -$1.340M -$620.0K -$670.0K -$520.0K $2.840M -$620.0K -$650.0K -$1.310M $510.0K -$2.970M -$1.920M -$2.510M -$2.780M -$670.0K -$600.0K $170.0K -$710.0K -$480.0K -$3.400M -$6.120M -$2.330M -$2.470M -$1.620M -$310.0K
YoY Change -1.69% 65857.29% 108.44% -99.36% 17.91% 116.13% -7.46% 28.85% -118.31% -558.06% -4.62% -50.38% -356.86% -117.17% 54.69% -23.51% -9.71% 314.93% 11.67% -452.94% -123.94% 47.92% -85.88% -44.44% 162.66% -5.67% 52.47% 422.58% 138.46%
Income Tax $800.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
% Of Pretax Income 0.0% 0.0% 0.0%
Net Earnings -$13.77M -$14.01M -$3.889M -$1.451M -$1.581M -$1.339M -$617.4K -$670.0K -$521.9K $2.840M -$620.0K -$650.0K -$1.310M $510.0K -$2.970M -$1.920M -$2.510M -$2.780M -$670.0K -$600.0K $170.0K -$710.0K -$480.0K -$3.400M -$6.120M -$2.330M -$2.470M -$1.620M -$310.0K
YoY Change -1.69% 260.19% 168.07% -8.26% 18.13% 116.83% -7.85% 28.38% -118.38% -558.06% -4.62% -50.38% -356.86% -117.17% 54.69% -23.51% -9.71% 314.93% 11.67% -452.94% -123.94% 47.92% -85.88% -44.44% 162.66% -5.67% 52.47% 422.58% 138.46%
Net Earnings / Revenue -11276.98% -397.96% -654.04% -8758.21% -13479.65% -1722.3% -246.04% -2183.33% 5100.0% -5940.0% -1745.45% -3585.71% -2138.46% -446.67% -1200.0% 170.0% -887.5% -67.61% -6800.0% -5563.64% -1059.09% -380.0% -241.79% -15.42%
Basic Earnings Per Share
Diluted Earnings Per Share -$3.36 -$1.03 -$515.2K -$533.1K -$594.0K -$563.0K -$410.6K -$478.6K -$388.1K $2.119M -$2.385M -$2.500M -$5.696M $2.550M -$19.80M -$17.45M -$27.89M -$34.75M -$11.17M -$15.00M $5.667M -$23.67M -$16.00M -$113.3M -$306.0M -$116.5M -$123.5M -$162.0M -$31.00M

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995
Cash & Short-Term Investments $1.886M $1.853M $1.750M $20.00K $410.0K $1.280M $1.980M $130.0K $20.00K $320.0K $10.00K $10.00K $0.00 $0.00 $20.00K $10.00K $50.00K $210.0K $190.0K $10.00K $10.00K $70.00K $340.0K $1.300M $4.780M $6.890M $8.780M $1.110M
YoY Change 1.74% 5.91% 8650.0% -95.12% -67.97% -35.35% 1423.08% 550.0% -93.75% 3100.0% 0.0% -100.0% 100.0% -80.0% -76.19% 10.53% 1800.0% 0.0% -79.41% -73.85% -72.8% -30.62% -21.53% 690.99%
Cash & Equivalents $1.886M $1.853M $1.750M $20.00K $410.0K $1.280M $1.980M $130.0K $20.00K $320.0K $10.00K $10.00K $0.00 $0.00 $20.00K $10.00K $50.00K $210.0K
Short-Term Investments $0.00 $6.010M $5.980M $0.00
Other Short-Term Assets $419.5K $195.8K $470.0K $50.00K $30.00K $30.00K $80.00K $110.0K $20.00K $20.00K $60.00K $10.00K $10.00K $130.0K $90.00K $10.00K $30.00K $30.00K $0.00 $0.00 $10.00K $10.00K $50.00K $50.00K $30.00K $40.00K $70.00K $110.0K $30.00K
YoY Change 114.27% -58.34% 840.0% 66.67% 0.0% -62.5% -27.27% 450.0% 0.0% -66.67% 500.0% 0.0% -92.31% 44.44% 800.0% -66.67% 0.0% -100.0% 0.0% -80.0% 0.0% 66.67% -25.0% -42.86% -36.36% 266.67%
Inventory $167.6K $595.2K $0.00 $0.00 $0.00 $20.00K $10.00K $0.00 $0.00 $0.00 $0.00 $0.00 $50.00K $60.00K $50.00K
Prepaid Expenses
Receivables $460.00 $201.6K
Other Receivables $0.00 $0.00
Total Short-Term Assets $2.473M $2.846M $2.220M $80.00K $450.0K $1.300M $2.080M $260.0K $40.00K $340.0K $70.00K $20.00K $10.00K $140.0K $110.0K $20.00K $80.00K $250.0K $200.0K $10.00K $20.00K $10.00K $170.0K $440.0K $1.380M $4.820M $6.960M $8.890M $1.140M
YoY Change -13.1% 28.19% 2675.0% -82.22% -65.38% -37.5% 700.0% 550.0% -88.24% 385.71% 250.0% 100.0% -92.86% 27.27% 450.0% -75.0% -68.0% 25.0% 1900.0% -50.0% 100.0% -94.12% -61.36% -68.12% -71.37% -30.75% -21.71% 679.82%
Property, Plant & Equipment $876.6K $1.376M $1.190M $0.00 $10.00K $10.00K $30.00K $40.00K $10.00K $0.00 $0.00 $0.00 $0.00 $0.00 $10.00K $20.00K $20.00K $0.00 $0.00 $0.00 $80.00K $80.00K $90.00K $110.0K $120.0K $130.0K $150.0K $120.0K
YoY Change -36.28% 15.6% -100.0% 0.0% -66.67% -25.0% 300.0% -100.0% -50.0% 0.0% -100.0% 0.0% -11.11% -18.18% -8.33% -7.69% -13.33% 25.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $10.00K $110.0K $470.0K $480.0K
YoY Change -90.91% -76.6% -2.08%
Other Assets $208.8K $80.68K $90.00K
YoY Change 158.84% -10.36%
Total Long-Term Assets $29.37M $34.26M $38.60M $180.0K $150.0K $160.0K $210.0K $200.0K $80.00K $80.00K $90.00K $100.0K $110.0K $120.0K $130.0K $140.0K $140.0K $140.0K $120.0K $130.0K $160.0K $240.0K $210.0K $210.0K $180.0K $170.0K $290.0K $680.0K $650.0K
YoY Change -14.29% -11.24% 21344.44% 20.0% -6.25% -23.81% 5.0% 150.0% 0.0% -11.11% -10.0% -9.09% -8.33% -7.69% -7.14% 0.0% 0.0% 16.67% -7.69% -18.75% -33.33% 14.29% 0.0% 16.67% 5.88% -41.38% -57.35% 4.62%
Total Assets $31.84M $37.11M $40.82M $260.0K $600.0K $1.460M $2.290M $460.0K $120.0K $420.0K $160.0K $120.0K $120.0K $260.0K $240.0K $160.0K $220.0K $390.0K $320.0K $140.0K $180.0K $250.0K $380.0K $650.0K $1.560M $4.990M $7.250M $9.570M $1.790M
YoY Change
Accounts Payable $1.000M $150.0K $210.0K $120.0K $160.0K $0.00 $140.0K $70.00K $290.0K $360.0K $810.0K $540.0K $320.0K $510.0K $100.0K $150.0K $40.00K $170.0K $160.0K $870.0K $880.0K $960.0K $520.0K $90.00K $80.00K $140.0K $150.0K
YoY Change 566.67% -28.57% 75.0% -25.0% -100.0% 100.0% -75.86% -19.44% -55.56% 50.0% 68.75% -37.25% 410.0% -33.33% 275.0% -76.47% 6.25% -81.61% -1.14% -8.33% 84.62% 477.78% 12.5% -42.86% -6.67%
Accrued Expenses $1.182M $1.212M $1.000M $0.00 $0.00 $0.00 $1.050M $950.0K $920.0K $830.0K $740.0K $630.0K $680.0K $600.0K $510.0K $550.0K $430.0K $310.0K $250.0K $100.0K $90.00K $230.0K $140.0K $340.0K $590.0K
YoY Change -2.48% 21.24% -100.0% 10.53% 3.26% 10.84% 12.16% 17.46% -7.35% 13.33% 17.65% -7.27% 27.91% 38.71% 24.0% 150.0% 11.11% -60.87% 64.29% -58.82% -42.37%
Deferred Revenue
YoY Change
Short-Term Debt $42.00K $884.0K $3.590M $950.0K $440.0K $510.0K $890.0K $790.0K $380.0K $230.0K $3.530M $2.850M $2.370M $2.200M $2.000M $2.000M $2.000M $2.000M $2.090M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change -95.25% -75.38% 277.89% 115.91% -13.73% -42.7% 12.66% 107.89% 65.22% -93.48% 23.86% 20.25% 7.73% 10.0% 0.0% 0.0% 0.0% -4.31%
Long-Term Debt Due $0.00 $376.5K $3.380M $1.050M $1.050M $10.00K $10.00K
YoY Change -100.0% -88.86% 0.0% 10400.0% 0.0%
Total Short-Term Liabilities $1.337M $2.473M $30.59M $1.100M $750.0K $730.0K $1.820M $1.270M $590.0K $300.0K $4.940M $4.240M $4.220M $3.630M $4.990M $3.140M $2.780M $2.750M $2.650M $1.770M $1.640M $1.190M $1.140M $1.060M $610.0K $320.0K $210.0K $480.0K $1.150M
YoY Change -45.94% -91.92% 2680.91% 46.67% 2.74% -59.89% 43.31% 115.25% 96.67% -93.93% 16.51% 0.47% 16.25% -27.25% 58.92% 12.95% 1.09% 3.77% 49.72% 7.93% 37.82% 4.39% 7.55% 73.77% 90.63% 52.38% -56.25% -58.26%
Long-Term Debt $5.922M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $150.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $1.070M $1.060M $2.120M $2.080M $2.000M $1.000M $2.600M $2.600M $2.300M $2.000M
YoY Change -100.0% -100.0% 0.94% -50.0% 1.92% 4.0% 100.0% -61.54% 0.0% 13.04% 15.0%
Other Long-Term Liabilities $135.8K $8.100K $30.00K
YoY Change 1576.91% -73.0%
Total Long-Term Liabilities $6.057M $8.100K $30.00K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $150.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $1.070M $1.060M $2.120M $2.080M $2.000M $1.000M $2.600M $2.600M $2.300M $2.000M
YoY Change 74682.59% -73.0% -100.0% -100.0% 0.94% -50.0% 1.92% 4.0% 100.0% -61.54% 0.0% 13.04% 15.0%
Total Liabilities $7.394M $2.481M $30.63M $1.100M $750.0K $730.0K $1.820M $1.270M $590.0K $450.0K $4.940M $4.240M $4.220M $3.630M $4.990M $3.140M $2.780M $2.750M $2.650M $2.830M $2.700M $3.310M $3.220M $3.060M $1.610M $2.920M $2.810M $2.780M $3.150M
YoY Change 198.03% -91.9% 2684.55% 46.67% 2.74% -59.89% 43.31% 115.25% 31.11% -90.89% 16.51% 0.47% 16.25% -27.25% 58.92% 12.95% 1.09% 3.77% -6.36% 4.81% -18.43% 2.8% 5.23% 90.06% -44.86% 3.91% 1.08% -11.75%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995
Basic Shares Outstanding
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $6.0614 Million

About Ainos, Inc.

Ainos, Inc. is a diversified medtech company, which engages in the development of medical technologies for point-of-care testing and safe and novel medical treatment for a broad range of disease indications. The company is headquartered in San Diego, California and currently employs 46 full-time employees. The firm's products include VELDONA clinical-stage human therapeutics, VELDONA Pet cytoprotein health supplements, and telehealth-friendly POCTs powered by its AI Nose technology platform. VELDONA Pet is formulated to address a variety of health issues in dogs and cats, including skin, gum, emotion, discomfort caused by allergies, eye, and weight-related issues. Its pipeline of products, which are under development, includes VELDONA human drugs, VOC POCT-Ainos Flora, VOC platform-NISD co-development, VOC POCT-Ainos Pen, VOC POCT-CHS430 and Synthetic RNA. VELDONA human drugs are the high-priority programs include oral warts for human immunodeficiency virus seropositive patients, common cold, influenza, Sjogrens syndrome and treatment for mild COVID-19 symptoms.

Industry: Pharmaceutical Preparations Peers: ABVC BIOPHARMA, INC. AIM ImmunoTech Inc. Neurogene Inc. Aravive, Inc. Oruka Therapeutics, Inc. Codiak BioSciences, Inc. Harpoon Therapeutics, Inc. MAIA Biotechnology, Inc.